Norbert Nagel

USPTO Granted Patents = 9 (Patent Applications = 2)

CIPO Patents = 4

EPO Patents = 9 (Patent Applications = 8)

Average Co-Inventor Count = 5.4

ph-index = 1

Forward Citations = 2(Granted Patents)

Company Filing History:

Sanofi-a Ventis Deutschland Gmbh

patents

Years Active: 2013-2023

Loading Chart...

9 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 11590206 - Liquid pharmaceutical composition (2023-02-28),

2. 9145385 - Crystalline salts of R)-3-[6-amino-pyridin-3-yl]-2-(1-cyclohexy1-1H-imidazol-4-yl)-propionic acid (2015-09-29),

3. 9102657 - Sodium salt of (R)-3-[6-amino-pyridin-3-yl]-2-(1-cyclohexyl-1H-imidazol-4-yl)-propionic acid (2015-08-11),

4. 9067918 - Crystalline forms of 2-(2-methylamino-pyrimidin-4-yl)-1H-indole-5-carboxylic acid [ (S)-1-carbamoyl-2-(phenyl-pyrimidin-2-yl-amino)-ethyl ]-amide (2015-06-30),

5. 9056833 - Crystalline phases of 2'-{[2-(4-methoxy-phenyl)-acetylamino]-methyl}-biphenyl-2-carboxylic acid (2-pyridin-3-yl-ethyl)-amide (2015-06-16),

6. 8993602 - Benzoic acid salt of otamixaban (2015-03-31),

7. 8785608 - Crystalline heteroaromatic fluoroglycoside hydrates, pharmaceuticals comprising these compounds and their use (2014-07-22),

8. 8710078 - Crystalline solvates of 6-(piperidin-4-yloxy)-2H-isoquinolin-1-one hydrochloride (2014-04-29),

9. 8598201 - Polymorphs of 6-(piperidin-4-yloxy)-2H-isoquinolin-1-one hydrochloride (2013-12-03),

Title: Norbert Nagel: Innovator in Pharmaceutical Composition

Introduction

Norbert Nagel is a prominent inventor based in Frankfurt am Main, Germany. He has made significant contributions to the field of pharmaceuticals, holding a total of 9 patents. His work primarily focuses on developing innovative solutions for medical applications, particularly in the treatment of metabolic disorders.

Latest Patents

One of his latest patents is a liquid pharmaceutical composition that includes a peptide of SEQ ID NO.: 2 as an active pharmaceutical ingredient. This composition is designed for medical use in humans, specifically targeting disorders related to metabolic syndrome, diabetes, and obesity, as well as aiding in the reduction of excess food intake. Another notable patent involves crystalline salts of (R)-3-[6-amino-pyridin-3-yl]-2-(1-cyclohexyl-1H-imidazol-4-yl)-propionic acid. This invention pertains to a sodium salt of the compound, which is available in crystalline form and is intended for treating conditions that can be improved by administering an inhibitor of the enzyme TAFIa.

Career Highlights

Throughout his career, Norbert Nagel has worked with reputable companies such as Sanofi and Sanofi-Aventis Deutschland GmbH. His experience in these organizations has allowed him to refine his expertise in pharmaceutical development and innovation.

Collaborations

Norbert has collaborated with notable professionals in his field, including Bruno Baumgartner and Harald Berchtold. These partnerships have contributed to the advancement of his research and the successful development of his patents.

Conclusion

Norbert Nagel's contributions to pharmaceutical innovation demonstrate his commitment to improving medical treatments for various conditions. His patents reflect a deep understanding of the complexities of drug development and the potential for new therapies to enhance patient care.

This text is generated by artificial intelligence and may not be accurate.